| Income Statement |
| Operating Expenses | 59.78M |
|
| Research and Development Expense | 48.55M |
| Selling, General and Administrative Expense | 11.23M |
| Operating Income | -59.78M |
| Net Income | -58.16M |
| Net Income Common Stock | -58.16M |
| Net Income Common Stock (USD) | -58.16M |
| Consolidated Income | -58.16M |
| Earnings per Basic Share | -0.94 |
| Earnings per Basic Share (USD) | -0.94 |
| Earnings per Diluted Share | -0.94 |
| Earning Before Interest & Taxes (EBIT) | -58.16M |
| Earning Before Interest & Taxes (USD) | -58.16M |
| Weighted Average Shares | 61.86M |
| Weighted Average Shares Diluted | 61.86M |
| Balance Sheet |
| Cash and Equivalents | 175.71M |
| Cash and Equivalents (USD) | 175.71M |
| Current Assets | 175.26M |
| Property, Plant & Equipment Net | 115.89M |
| Total Assets | 306.01M |
| Debt Current | 11.66M |
| Total Debt | 155.99M |
| Current Liabilities | 49.57M |
| Debt Non-Current | 144.33M |
| Total Liabilities | 193.91M |
| Accumulated Retained Earnings (Deficit) | -1.62B |
| Shareholders Equity | 112.10M |
| Shareholders Equity (USD) | 112.10M |
| Assets Non-Current | 130.75M |
| Total Debt (USD) | 155.99M |
| Liabilities Non-Current | 144.33M |
| Trade and Non-Trade Payables | 11.34M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 6.34M |
| Net Cash Flow from Financing | 619.00K |
| Net Cash Flow / Change in Cash & Cash Equivalents | -40.33M |
| Capital Expenditure | -942.00K |
| Issuance (Purchase) of Equity Shares | 922.00K |
| Net Cash Flow from Investing | -942.00K |
| Net Cash Flow from Operations | -40.01M |
| Share Based Compensation | 12.16M |